GPT Group

World-Leading Building Operations Solution CIM Raises US$6.7 Million in Series A Round

Retrieved on: 
Tuesday, September 20, 2022
Carbon, Dell, Private equity, Efficiency, Machine learning, GPT Group, The, Growth, National Directorate of Intelligence and Prevention Services, REIT, Environment, FUM, Scentre Group, Venture capital, CBRE, CEO, QIC, B Corporation (certification), Fault, CIM, Cascade, GLOBE, Airport

Headquartered in Sydney, CIM also operates in Europe with landmark clients globally including Charter Hall, Scentre Group, Lendlease, Dell, QIC , The GPT Group , and CBRE.

Key Points: 
  • Headquartered in Sydney, CIM also operates in Europe with landmark clients globally including Charter Hall, Scentre Group, Lendlease, Dell, QIC , The GPT Group , and CBRE.
  • Ed Bigazzi, from Five V Capital says, "CIM is unique in that it solves three problems at once.
  • First, it reduces the carbon footprint for a building which moves us towards net-zero and makes the building more valuable.
  • The award-winning PEAK Platform integrates building intelligence, machine learning and technical engineering support to improve efficiency, sustainability and comfort.

A Pharmaceutical Dynamo Committed to Driving Innovation within Drug Development Joins Captario as Director of Strategic Account Management

Retrieved on: 
Wednesday, August 10, 2022
Industry, R, Hotel manager, Growth, SCB-2019, Software as a service, Partnership, Drug development, PMC, GPT Group, Decision support system, Management, Risk management

BOSTON, Aug. 10, 2022 /PRNewswire-PRWeb/ -- Captario, the decision-making SaaS platform company with operations in Europe, Australia, and the United States, is pleased to announce the appointment of Matthew Kokkonen to the role of Director, Strategic Account Management. With continued growth across global pharma and biotech companies, this new hire signifies Captario's deepening commitment to customer delivery in both execution and strategic partnership.

Key Points: 
  • With continued growth across global pharma and biotech companies, this new hire signifies Captario's deepening commitment to customer delivery in both execution and strategic partnership.
  • We are deeply committed to driving innovation within drug development decision-making, and we know the best way to do this is to put our customers at the center of our business.
  • Before joining Captario, Matthew has held various high-level roles in pharma, including portfolio management, R&D, and consulting positions.
  • Captario AB develops and implements Captario SUM, a SaaS-based decision analytics platform for individual drug products and portfolios.

Demyst appoints new Chairman of the Board: Michael Cameron, formerly CEO & Managing Director of Suncorp Group

Retrieved on: 
Thursday, December 23, 2021
GPT Group, Organization, Director, CEO, Commonwealth Bank, Insurance, Board, Suncorp Group, Growth, CFO, Management

"Our Board of Directors comprises a dedicated global team of industry leaders committed to operationalizing external data" said Mark Hookey, Founder and CEO of Demyst.

Key Points: 
  • "Our Board of Directors comprises a dedicated global team of industry leaders committed to operationalizing external data" said Mark Hookey, Founder and CEO of Demyst.
  • Michael Cameron has previously been a CEO of Suncorp Group and The GPT Group, spanning 10 years, and a non-executive director of Suncorp Group for four years.
  • Demyst is dealing with these changes in innovative ways which will benefit all Demyst stakeholders for years to come," said Cameron.
  • Mark Hookey, Demyst's CEO, said, "Demyst is growing fast as a purpose-driven and comprehensive platform data provider adding incredible value to customers.